Subsequently, several cohorts of ALS and ALS-FTD patients were screened for CHCHD10 mutations and a number of candidate rare, predicted deleterious mutations were identified (Johnson et al., 2014; Dols-Icardo et al., 2015). This evidence concerns the gene CHCHD10 and amyotrophic lateral sclerosis.